SyntheX
SyntheX expands the druggable proteome using synthetic biology-driven drug discovery platforms. The platforms rely on empirical intracellular selection to discover protein interaction modulators. These can discover compounds that disrupt a specific protein-protein interaction (PPI), or achieve the inverse, and bring an E3 ubiquitin ligase and a neosubstrate of interest together to achieve functional protein degradation. In addition to external discovery collaborations, the platforms have generated an internal oncology pipeline focused on unique mechanisms of action around genetically validated targets.
Tech Stack (26 technologies)
Frequently Asked Questions
What technologies does SyntheX use?+
SyntheX uses 26 technologies including AOS, Flickity, Google Analytics.
What industry is SyntheX in?+
SyntheX operates in the Biotechnology industry.
Where is SyntheX based?+
SyntheX is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026